ATE441116T1 - Verfahren zur selektiven bestimmung von procalcitonin 1-116 für diagnostische zwecke sowie antikírper und kits zur ausführung dieses verfahrens - Google Patents
Verfahren zur selektiven bestimmung von procalcitonin 1-116 für diagnostische zwecke sowie antikírper und kits zur ausführung dieses verfahrensInfo
- Publication number
- ATE441116T1 ATE441116T1 AT08715933T AT08715933T ATE441116T1 AT E441116 T1 ATE441116 T1 AT E441116T1 AT 08715933 T AT08715933 T AT 08715933T AT 08715933 T AT08715933 T AT 08715933T AT E441116 T1 ATE441116 T1 AT E441116T1
- Authority
- AT
- Austria
- Prior art keywords
- procalcitonin
- kits
- antibodies
- carrying
- diagnostic purposes
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/585—Calcitonins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102007009751A DE102007009751A1 (de) | 2007-02-28 | 2007-02-28 | Verfahren zur selektiven Bestimmung von Procalcitonin 1-116 für diagnostische Zwecke sowie Antikörper und Kits zur Durchführung eines solchen Verfahrens |
PCT/EP2008/001373 WO2008104321A1 (en) | 2007-02-28 | 2008-02-21 | Method for the selective determination of procalcitonin 1-116 for diagnostic purposes and antibodies and kits for carrying out such a method |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE441116T1 true ATE441116T1 (de) | 2009-09-15 |
Family
ID=39327375
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT08715933T ATE441116T1 (de) | 2007-02-28 | 2008-02-21 | Verfahren zur selektiven bestimmung von procalcitonin 1-116 für diagnostische zwecke sowie antikírper und kits zur ausführung dieses verfahrens |
Country Status (8)
Country | Link |
---|---|
US (2) | US8354506B2 (de) |
EP (1) | EP2032992B1 (de) |
JP (1) | JP5520609B2 (de) |
CN (2) | CN107422133A (de) |
AT (1) | ATE441116T1 (de) |
DE (2) | DE102007009751A1 (de) |
ES (1) | ES2331936T3 (de) |
WO (1) | WO2008104321A1 (de) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8283131B2 (en) | 2008-10-28 | 2012-10-09 | Assistance Publique-Hopitaux De Paris | Methods and kits for the rapid determination of patients at high risk of death during severe sepsis and septic shock |
JP5619016B2 (ja) * | 2008-10-28 | 2014-11-05 | アシスタンスピュブリック−オピトド パリAssistance Publique−Hopitaux De Paris | 重症敗血症及び敗血症性ショック中の死亡の危険性が高い患者を迅速に決定するための方法及びキット |
TR201806292T4 (tr) * | 2009-04-28 | 2018-06-21 | Brahms Gmbh | Prokalsi̇toni̇ni̇n saptanmasi i̇çi̇n i̇mmünoloji̇k test |
ES2617982T3 (es) * | 2009-08-28 | 2017-06-20 | B.R.A.H.M.S Gmbh | Procalcitonina para la prognosis de eventos adversos |
US8383332B2 (en) * | 2009-10-13 | 2013-02-26 | B.R.A.H.M.S. Gmbh | Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with acute stroke or transient ischemic attack |
WO2011110565A1 (en) * | 2010-03-08 | 2011-09-15 | B.R.A.H.M.S Gmbh | Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with non-specific complaints |
ITRM20100121A1 (it) * | 2010-03-18 | 2011-09-19 | Univ Pisa | Marcatori molecolari per infezioni delle vie urinarie. |
JP5956434B2 (ja) | 2011-05-19 | 2016-07-27 | 持田製薬株式会社 | 血液検体を用いた呼吸器感染症の診断 |
CN103635805B (zh) | 2011-05-19 | 2016-03-02 | 持田制药株式会社 | 使用尿样本的呼吸道传染病的诊断 |
CN102702323B (zh) * | 2011-09-15 | 2015-04-22 | 重庆业为基生物科技有限公司 | 降钙素原b细胞表位肽段及其单克隆抗体的应用 |
CN102643332B (zh) * | 2011-09-15 | 2014-12-31 | 重庆业为基生物科技有限公司 | 人pct的b细胞表位肽段及其单克隆抗体的应用 |
IN2014MN01780A (de) | 2012-02-09 | 2015-07-03 | Memed Diagnostics Ltd | |
US9488659B2 (en) * | 2012-04-12 | 2016-11-08 | B.R.A.H.M.S. Gmbh | Prognosis of adverse events in patients with suspected chronic heart failure |
CN103018456B (zh) * | 2012-11-29 | 2014-10-01 | 深圳市伯劳特生物制品有限公司 | 降钙素原检测试纸条及其制备方法 |
US10260111B1 (en) | 2014-01-20 | 2019-04-16 | Brett Eric Etchebarne | Method of detecting sepsis-related microorganisms and detecting antibiotic-resistant sepsis-related microorganisms in a fluid sample |
CN104792997B (zh) * | 2014-01-22 | 2017-07-11 | 天津汇滨生物科技有限公司 | 一种人降钙素原免疫检测试剂盒及其制备方法与应用 |
CN103913579B (zh) * | 2014-03-24 | 2016-05-25 | 北京普恩光德生物科技开发有限公司 | 一种降钙素原检测试剂盒 |
EP3699930B1 (de) | 2014-08-14 | 2024-02-07 | MeMed Diagnostics Ltd. | Rechnerische analyse biologischer daten mit verteiler und hyperebene |
WO2016059636A1 (en) | 2014-10-14 | 2016-04-21 | Memed Diagnostics Ltd. | Signatures and determinants for diagnosing infections in non-human subjects and methods of use thereof |
US9375478B1 (en) | 2015-01-30 | 2016-06-28 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9750785B2 (en) | 2015-01-30 | 2017-09-05 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9925233B2 (en) | 2015-01-30 | 2018-03-27 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9937223B2 (en) | 2015-01-30 | 2018-04-10 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9687526B2 (en) | 2015-01-30 | 2017-06-27 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9744209B2 (en) | 2015-01-30 | 2017-08-29 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
CN104714017A (zh) * | 2015-02-06 | 2015-06-17 | 北京豪迈生物工程有限公司 | 一种定量检测降钙素原的方法 |
CN105801697A (zh) * | 2015-07-09 | 2016-07-27 | 南京诺尔曼生物技术有限公司 | 人源降钙素原的单克隆抗体其制备方法和用途 |
CN106399294B (zh) * | 2015-12-07 | 2019-07-09 | 湖南师范大学 | 一种抗人降钙素原蛋白n末端抗原表位的单克隆抗体7h8的制备 |
EP3423590A4 (de) | 2016-03-03 | 2020-02-26 | Memed Diagnostics Ltd. | Rna-determinanten zur unterscheidung zwischen bakteriellen und viralen infektionen |
CN105758832A (zh) * | 2016-04-06 | 2016-07-13 | 上海奥普生物医药有限公司 | 一种基于微球的杯式时间分辨荧光降钙素原分析试剂盒及其制备方法和应用 |
EP4141448A1 (de) | 2016-07-10 | 2023-03-01 | MeMed Diagnostics Ltd. | Proteinsignaturen zur unterscheidung zwischen bakteriellen und viralen infektionen |
WO2018011796A1 (en) | 2016-07-10 | 2018-01-18 | Memed Diagnostics Ltd. | Early diagnosis of infections |
US11385241B2 (en) | 2016-09-29 | 2022-07-12 | Memed Diagnostics Ltd. | Methods of prognosis and treatment |
US11353456B2 (en) | 2016-09-29 | 2022-06-07 | Memed Diagnostics Ltd. | Methods of risk assessment and disease classification for appendicitis |
CN107817347A (zh) * | 2017-09-25 | 2018-03-20 | 南京航思生物科技有限公司 | 一种均相发光法检测动物降钙素原的试剂盒 |
JP7051096B2 (ja) * | 2018-05-30 | 2022-04-11 | 国立大学法人山口大学 | ウシプロカルシトニンを特異的に認識する抗体、その抗原結合断片、および、その使用 |
CN116559471A (zh) * | 2018-07-18 | 2023-08-08 | 科美博阳诊断技术(上海)有限公司 | 一种降钙素原均相化学发光检测试剂盒、检测方法与装置 |
CN109633163B (zh) * | 2018-11-28 | 2022-03-04 | 浙江聚康生物工程有限公司 | 降钙素原/c反应蛋白二合一检测试剂盒 |
CN115136009A (zh) | 2020-04-09 | 2022-09-30 | B.R.A.H.M.S有限公司 | 用于呼吸道感染诊断的生物标志物 |
CN115980341A (zh) * | 2022-12-26 | 2023-04-18 | 南京珀尔泰生物技术有限公司 | 一种新型胶体金法定量检测降钙素原pct免疫层析试纸条及其制备方法 |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2570703B1 (fr) | 1984-09-26 | 1988-07-08 | Commissariat Energie Atomique | Complexes macropolycycliques de terres rares et application a titre de marqueurs fluorescents |
US4822733A (en) | 1985-05-28 | 1989-04-18 | Amoco Corporation | Lifetime-resolved assay procedures |
FR2664699B1 (fr) | 1990-07-13 | 1995-08-18 | Cis Bio Int | Procede d'amplification du signal d'emission d'un compose luminescent. |
DE4227454C1 (de) * | 1992-08-19 | 1994-02-03 | Henning Berlin Gmbh | Verfahren zur Früherkennung, zur Erkennung des Schweregrads sowie zur therapiebegleitenden Verlaufsbeurteilung einer Sepsis sowie Mittel zur Durchführung des Verfahrens |
DE19600875C1 (de) | 1996-01-12 | 1997-06-26 | Brahms Diagnostica Gmbh | Diagnostisches Verfahren zur Bestimmung der Ätiologie entzündlicher Prozesse |
US5993811A (en) * | 1997-02-03 | 1999-11-30 | Biology Associates, Llc | Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis |
DE19847690A1 (de) | 1998-10-15 | 2000-04-20 | Brahms Diagnostica Gmbh | Verfahren und Substanzen für die Diagnose und Therapie von Sepsis und sepsisähnlichen systemischen Infektionen |
DE19903336C2 (de) * | 1999-01-28 | 2000-12-14 | Brahms Diagnostica Gmbh | Gebrauchsfertige Kalibratoren für die Bestimmung von Procalcitonin |
DE10041215A1 (de) * | 1999-12-22 | 2001-10-04 | Dade Behring Marburg Gmbh | Gegen Procalcitonin gerichtete Antikörper, ihre Herstellung und Verwendung |
DE50014159D1 (de) * | 1999-12-22 | 2007-04-26 | Dade Behring Marburg Gmbh | Lösungen von humanem Procalcitonin |
DE50015156D1 (de) | 1999-12-22 | 2008-06-26 | Dade Behring Marburg Gmbh | Gegen Procalcitonin gerichtete Antikörper, ihre Herstellung und Verwendung |
EP1270740A1 (de) * | 2001-06-29 | 2003-01-02 | SIRS-Lab GmbH | Biochip und dessen Verwendung zur Bestimmung von Entzündungen |
EP1355158A1 (de) | 2002-04-19 | 2003-10-22 | B.R.A.H.M.S Aktiengesellschaft | Verfahren zur Diagnose von Entzündungserkrankungen und Infektionen unter Bestimmung des Phosphoproteins LASP-1 als Inflammationsmarker |
EP1355159A1 (de) | 2002-04-19 | 2003-10-22 | B.R.A.H.M.S Aktiengesellschaft | Verwendungen von Fragmenten der Carbamoylphosphat Synthetase 1 (CPS 1) für die Diagnose von Entzündungserkrankungen und Sepsis |
EP1369693A1 (de) * | 2002-06-04 | 2003-12-10 | B.R.A.H.M.S Aktiengesellschaft | Verfahren zur Sepsisdiagnose und zur Kontrolle von Spenderblut durch Bestimmung von anti-Asialo-Gangliosid-Antikörpern |
EP1369118A1 (de) | 2002-06-04 | 2003-12-10 | B.R.A.H.M.S Aktiengesellschaft | Verfahren und Mittel zur Prävention, Hemmung und Therapie von Sepsis |
DE10316583A1 (de) | 2003-04-10 | 2004-10-28 | B.R.A.H.M.S Aktiengesellschaft | Bestimmung eines midregionalen Proadrenomedullin-Teilpeptids in biologischen Flüssigkeiten zu diagnostischen Zwecken, sowie Immunoassays für die Durchführung einer solchen Bestimmung |
EP1562046A1 (de) | 2004-02-03 | 2005-08-10 | B.R.A.H.M.S Aktiengesellschaft | Diagnose von Sepsis durch selektive Bestimmung der Konzentration der Cu/Zn Superoxiddismutase (Cu/Zn SOD) in Patientenproben |
ES2255003T3 (es) | 2004-02-13 | 2006-06-16 | B.R.A.H.M.S Aktiengesellschaft | Procedimiento para determinar la formacion de endotelinas con fines diagnostico medico, y anticuerpos y kits para realizar un procedimiento de este tipo. |
DE102004047968A1 (de) * | 2004-10-01 | 2006-04-06 | B.R.A.H.M.S Ag | Bestimmung von Gastrokine 1 (GKN1) als Biomarker für Entzündungen und Infektionen |
DE102005011421A1 (de) | 2005-03-11 | 2006-09-14 | Brahms Aktiengesellschaft | Bestimmung von kurzkettiger SRL-Alkoholdehydrogenase (DHRS4) als Biomarker für Entzündungen und Infektionen |
DE102005034174A1 (de) | 2005-07-21 | 2007-02-08 | B.R.A.H.M.S Ag | Liquordiagnostisches in vitro Verfahren zur Diagnose von Demenz-Erkrankungen und neuroinflammatorischen Erkrankungen |
DE102005036094A1 (de) | 2005-08-01 | 2007-02-08 | B.R.A.H.M.S Ag | In vitro Verfahren zur Diagnose von neurodegenerativen Erkrankungen |
US8906857B2 (en) | 2005-12-01 | 2014-12-09 | B.R.A.H.M.S. Gmbh | Methods for the diagnosis and treatment of critically ill patients with endothelin, endothelin agonists and adrenomedullin antagonists |
DE102006046996A1 (de) | 2006-10-01 | 2008-04-03 | Brahms Aktiengesellschaft | Diagnose von Infektionen oder Entzündungserkrankungen der Atemwege und Lunge assoziiert mit Herzinsuffizienz |
EP2084543B1 (de) | 2006-10-26 | 2017-10-18 | B.R.A.H.M.S GmbH | Risikostratifizierung des akuten koronarsyndroms mittels fragmenten / teilpeptiden des provasopressins, insbesondere copeptin oder neurophysin ii |
DE102006052916A1 (de) | 2006-11-08 | 2008-05-15 | Brahms Aktiengesellschaft | Diagnose und Risikostratifizierung von Diabetes mellitus mittels MR-proADM |
US9012151B2 (en) | 2006-11-09 | 2015-04-21 | B.R.A.H.M.S. Gmbh | Methods of diagnosis and risk stratification of adverse events in post myocardial infarction patients using pro-adrenomedullin |
DE102006053442A1 (de) | 2006-11-12 | 2008-05-15 | Brahms Aktiengesellschaft | Diagnose und Risikostratifizierung von Infektionen und chronischen Erkrankungen der Atemwege und Lunge mittels proVasopressin, insbesondere Copeptin oder Neurophysin II |
DE102006060112A1 (de) | 2006-12-20 | 2008-06-26 | Brahms Aktiengesellschaft | Diagnose und Risikostratifizierung mittels dem neuen Marker CT-proADM |
-
2007
- 2007-02-28 DE DE102007009751A patent/DE102007009751A1/de not_active Withdrawn
-
2008
- 2008-02-21 WO PCT/EP2008/001373 patent/WO2008104321A1/en active Application Filing
- 2008-02-21 US US12/529,089 patent/US8354506B2/en active Active
- 2008-02-21 AT AT08715933T patent/ATE441116T1/de active
- 2008-02-21 ES ES08715933T patent/ES2331936T3/es active Active
- 2008-02-21 JP JP2009551115A patent/JP5520609B2/ja active Active
- 2008-02-21 CN CN201611048598.7A patent/CN107422133A/zh active Pending
- 2008-02-21 DE DE602008000117T patent/DE602008000117D1/de active Active
- 2008-02-21 CN CN200880005375A patent/CN101617230A/zh active Pending
- 2008-02-21 EP EP08715933A patent/EP2032992B1/de active Active
-
2013
- 2013-01-14 US US13/740,386 patent/US9664689B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN101617230A (zh) | 2009-12-30 |
WO2008104321A1 (en) | 2008-09-04 |
CN107422133A (zh) | 2017-12-01 |
DE102007009751A1 (de) | 2008-09-04 |
EP2032992B1 (de) | 2009-08-26 |
US9664689B2 (en) | 2017-05-30 |
ES2331936T3 (es) | 2010-01-20 |
US20100056763A1 (en) | 2010-03-04 |
EP2032992A1 (de) | 2009-03-11 |
JP2010519322A (ja) | 2010-06-03 |
US8354506B2 (en) | 2013-01-15 |
JP5520609B2 (ja) | 2014-06-11 |
US20130122515A1 (en) | 2013-05-16 |
DE602008000117D1 (de) | 2009-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE441116T1 (de) | Verfahren zur selektiven bestimmung von procalcitonin 1-116 für diagnostische zwecke sowie antikírper und kits zur ausführung dieses verfahrens | |
NZ613646A (en) | Elisa for vegf | |
BRPI0509419A (pt) | método de ensaio imunossorvente ligado por enzimas, anticorpos, hibridoma e kit de imunoensaio | |
BRPI0410261B8 (pt) | anticorpo monoclonal que se liga especificamente ao probnp, métodos para detecção específica de probnp in vitro e para diagnóstico de insuficiência cardíaca in vitro, kit para medição de probnp, e linhagem celular de hibridoma mab 1.21.3 | |
DE502005010086D1 (de) | Monoklonaler antikörper gegen humanen frizzled-4-rezeptor | |
JP2010520996A5 (ja) | 敗血症の合併症の検査 | |
NZ599105A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
NZ600828A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
NZ592552A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
HK1099807A1 (en) | Method for detecting the formation of endothelins for medical diagnosis, and antibodies and kits for carrying out one such method | |
WO2005103698A3 (en) | Methods and antibodies for nitrofuran detection | |
MX2007014815A (es) | Metodos de inmunoanalisis mejorados. | |
CL2008003561A1 (es) | Construccion de union a il - 13 que comprende a lo menos un dominio simple (dab) de anticuerpo injertado en un anticuerpo monoclonal ( mabdab); polinucleotido y celula huesped; procedimiento para preparar la construccion; composicion farmaceutica que la comprende y uso para tratar cancer o enfermedades inflamatorias. | |
BRPI0707645B8 (pt) | métodos in vitro para detecção de câncer em um indivíduo e para avaliação de prognóstico de um indivíduo tendo, ou suspeito de ter, câncer ovariano | |
WO2013132347A3 (en) | Improved elisa immunoassay for calprotectin | |
DE60130538D1 (de) | Humanisierte antikörper gegen ccr2 und verfahren zur deren verwendung | |
EP2295465A3 (de) | Menschliche monoklonale Antikörper gegen das Influenza M2 Protein sowie Methoden zu deren Herstellung und Verwendung | |
ATE554106T1 (de) | Antikörper für onkogene stämme von hpv und verfahren zu deren verwendung | |
WO2010038974A3 (ko) | 이뮤노글로블린 에이 신증과 티지비엠 신증의 진단용 조성물 및 키트 | |
WO2007024735A3 (en) | Method and antibodies for detecting nitrofuran | |
BRPI0820885B8 (pt) | "anticorpo ou fraguimento do mesmo, célula de hibridoma, polinucleotídeo, polipeptídeo compreendendoum domínio de cadeia pesada ou leve de anticorpo, método para detecção de gravidez em um animal bovino, kit e método de purificação de um antígeno principal associado à gravidez (pag)". | |
DE602006014581D1 (de) | Turbidimetrischer immunoassay zur beurteilung von humanem cystatin c | |
DK2054443T3 (da) | Antistoffer mod en epitop fra AGR2, assays og hybridomer | |
WO2005106494A3 (en) | Monoclonal antibodies, hybridomas, improved method for determining the protein ptx3 and kit for said determination | |
ATE553127T1 (de) | Oligoklonale anti-clusterin-antikörper zur diagnose und vorhersage der aggressivität von tumoren, diagnostisches verfahren und damit in zusammenhang stehende kits |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 2032992 Country of ref document: EP |